The BCR/ABL-inhibitors Imatinib, Nilotinib and Dasatinib differentially affect NK cell reactivitySALIH, Julia; HILPERT, Julia; PLACKE, Theresa et al.International journal of cancer (Print). 2010, Vol 127, Num 9, pp 2119-2128, issn 0020-7136, 10 p.Article

Platelet-Derived MHC Class I Confers a Pseudonormal Phenotype to Cancer Cells That Subverts the Antitumor Reactivity of Natural Killer Immune CellsPLACKE, Theresa; ÖRGEL, Melanie; SCHALLER, Martin et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 2, pp 440-448, issn 0008-5472, 9 p.Article